{"id":"https://openalex.org/W2074766085","doi":"https://doi.org/10.1254/jphs.qt-a1","title":"QT PRODACT: A Multi-site Study of In Vitro Action Potential Assays on 21 Compounds in Isolated Guinea-Pig Papillary Muscles","display_name":"QT PRODACT: A Multi-site Study of In Vitro Action Potential Assays on 21 Compounds in Isolated Guinea-Pig Papillary Muscles","publication_year":2005,"publication_date":"2005-01-01","ids":{"openalex":"https://openalex.org/W2074766085","doi":"https://doi.org/10.1254/jphs.qt-a1","mag":"2074766085","pmid":"https://pubmed.ncbi.nlm.nih.gov/16493184"},"language":"en","primary_location":{"id":"doi:10.1254/jphs.qt-a1","doi":"https://doi.org/10.1254/jphs.qt-a1","is_oa":true,"landing_page_url":"https://doi.org/10.1254/jphs.qt-a1","pdf_url":"https://www.jstage.jst.go.jp/article/jphs/99/5/99_5_423/_pdf","source":{"id":"https://openalex.org/S163931769","display_name":"Journal of Pharmacological Sciences","issn_l":"1347-8613","issn":["1347-8613","1347-8648"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacological Sciences","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.jstage.jst.go.jp/article/jphs/99/5/99_5_423/_pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021055475","display_name":"Seiji Hayashi","orcid":"https://orcid.org/0009-0002-7893-5546","observed_orcids":["https://orcid.org/0009-0002-7893-5546"]},"institutions":[{"id":"https://openalex.org/I4210162696","display_name":"Nippon Shinyaku (Japan)","ror":"https://ror.org/05wyn3p10","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210162696"]},{"id":"https://openalex.org/I4405255266","display_name":"Japan Pharmaceutical Manufacturers Association","ror":"https://ror.org/02t1m5632","country_code":"JP","type":"nonprofit","lineage":["https://openalex.org/I4405255266"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Seiji Hayashi","raw_affiliation_strings":["Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, Tokyo, Japan. s.hayashi@po.nippon-shinyaku.co.jp","Discovery Research Laboratories, Nippon Shinyaku Co., Ltd., Japan","Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, Tokyo, Japan. s.hayashi@po.nippon-shinyaku.co.jp","institution_ids":["https://openalex.org/I4405255266"]},{"raw_affiliation_string":"Discovery Research Laboratories, Nippon Shinyaku Co., Ltd., Japan","institution_ids":["https://openalex.org/I4210162696"]},{"raw_affiliation_string":"Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, Japan","institution_ids":["https://openalex.org/I4405255266"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050191709","display_name":"Yoshihide Kii","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I31591830","display_name":"Sumitomo Dainippon Pharma (Japan)","ror":"https://ror.org/04sapgw72","country_code":"JP","type":"company","lineage":["https://openalex.org/I31591830"]},{"id":"https://openalex.org/I4405255266","display_name":"Japan Pharmaceutical Manufacturers Association","ror":"https://ror.org/02t1m5632","country_code":"JP","type":"nonprofit","lineage":["https://openalex.org/I4405255266"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoshihide Kii","raw_affiliation_strings":["Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, Japan","Safety Research Laboratories, Dainippon Sumitomo Pharma Co., Ltd., Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, Japan","institution_ids":["https://openalex.org/I4405255266"]},{"raw_affiliation_string":"Safety Research Laboratories, Dainippon Sumitomo Pharma Co., Ltd., Japan","institution_ids":["https://openalex.org/I31591830"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019676598","display_name":"Mitsuyasu Tabo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]},{"id":"https://openalex.org/I4405255266","display_name":"Japan Pharmaceutical Manufacturers Association","ror":"https://ror.org/02t1m5632","country_code":"JP","type":"nonprofit","lineage":["https://openalex.org/I4405255266"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Mitsuyasu Tabo","raw_affiliation_strings":["Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, Japan","Safety Assessment Department, Chugai Pharmaceutical Co., Ltd., Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, Japan","institution_ids":["https://openalex.org/I4405255266"]},{"raw_affiliation_string":"Safety Assessment Department, Chugai Pharmaceutical Co., Ltd., Japan","institution_ids":["https://openalex.org/I4405254473"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073178915","display_name":"Hitoshi Fukuda","orcid":"https://orcid.org/0000-0003-3803-8242","observed_orcids":["https://orcid.org/0000-0003-3803-8242"]},"institutions":[{"id":"https://openalex.org/I4405255266","display_name":"Japan Pharmaceutical Manufacturers Association","ror":"https://ror.org/02t1m5632","country_code":"JP","type":"nonprofit","lineage":["https://openalex.org/I4405255266"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hitoshi Fukuda","raw_affiliation_strings":["Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, Japan","Research Laboratories, Toyama Chemical Co., Ltd., Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, Japan","institution_ids":["https://openalex.org/I4405255266"]},{"raw_affiliation_string":"Research Laboratories, Toyama Chemical Co., Ltd., Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090435715","display_name":"Tetsuji Itoh","orcid":"https://orcid.org/0000-0002-4129-539X","observed_orcids":["https://orcid.org/0000-0002-4129-539X"]},"institutions":[{"id":"https://openalex.org/I4210118477","display_name":"Shionogi (Japan)","ror":"https://ror.org/01v3bqg10","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210118477"]},{"id":"https://openalex.org/I4405255266","display_name":"Japan Pharmaceutical Manufacturers Association","ror":"https://ror.org/02t1m5632","country_code":"JP","type":"nonprofit","lineage":["https://openalex.org/I4405255266"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tetsuji Itoh","raw_affiliation_strings":["Developmental Research Laboratories, Shionogi & Co., Ltd., Japan","Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Developmental Research Laboratories, Shionogi & Co., Ltd., Japan","institution_ids":["https://openalex.org/I4210118477"]},{"raw_affiliation_string":"Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, Japan","institution_ids":["https://openalex.org/I4405255266"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054623488","display_name":"Takashi Shimosato","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405255266","display_name":"Japan Pharmaceutical Manufacturers Association","ror":"https://ror.org/02t1m5632","country_code":"JP","type":"nonprofit","lineage":["https://openalex.org/I4405255266"]},{"id":"https://openalex.org/I4405274589","display_name":"Nissei Corporation (Japan)","ror":"https://ror.org/01zpca449","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405274589"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takashi Shimosato","raw_affiliation_strings":["Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, Japan","Research Department, NISSEI BILIS Co., Ltd., Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, Japan","institution_ids":["https://openalex.org/I4405255266"]},{"raw_affiliation_string":"Research Department, NISSEI BILIS Co., Ltd., Japan","institution_ids":["https://openalex.org/I4405274589"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111945690","display_name":"Hideto Amano","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405255266","display_name":"Japan Pharmaceutical Manufacturers Association","ror":"https://ror.org/02t1m5632","country_code":"JP","type":"nonprofit","lineage":["https://openalex.org/I4405255266"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hideto Amano","raw_affiliation_strings":["Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, Japan","Kashima Laboratory, Mitsubishi Chemical Safety Institute Ltd., Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, Japan","institution_ids":["https://openalex.org/I4405255266"]},{"raw_affiliation_string":"Kashima Laboratory, Mitsubishi Chemical Safety Institute Ltd., Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113947688","display_name":"Mamoru Sait\u014d","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405255266","display_name":"Japan Pharmaceutical Manufacturers Association","ror":"https://ror.org/02t1m5632","country_code":"JP","type":"nonprofit","lineage":["https://openalex.org/I4405255266"]},{"id":"https://openalex.org/I55881946","display_name":"Eisai (Japan)","ror":"https://ror.org/04vvh7p27","country_code":"JP","type":"company","lineage":["https://openalex.org/I55881946"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Mamoru Saito","raw_affiliation_strings":["Drug Safety Research Laboratories, Eisai Co., Ltd., Japan","Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Safety Research Laboratories, Eisai Co., Ltd., Japan","institution_ids":["https://openalex.org/I55881946"]},{"raw_affiliation_string":"Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, Japan","institution_ids":["https://openalex.org/I4405255266"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031299062","display_name":"Hajime Morimoto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114030911","display_name":"Otsuka (Japan)","ror":"https://ror.org/013k5y296","country_code":"JP","type":"company","lineage":["https://openalex.org/I114030911"]},{"id":"https://openalex.org/I4405255266","display_name":"Japan Pharmaceutical Manufacturers Association","ror":"https://ror.org/02t1m5632","country_code":"JP","type":"nonprofit","lineage":["https://openalex.org/I4405255266"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hajime Morimoto","raw_affiliation_strings":["Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, Japan","Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd., Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, Japan","institution_ids":["https://openalex.org/I4405255266"]},{"raw_affiliation_string":"Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd., Japan","institution_ids":["https://openalex.org/I114030911"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Kiyoshi Yamada","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210115317","display_name":"Toray Industries, Inc. (Japan)","ror":"https://ror.org/029xh1r47","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210115317"]},{"id":"https://openalex.org/I4405255266","display_name":"Japan Pharmaceutical Manufacturers Association","ror":"https://ror.org/02t1m5632","country_code":"JP","type":"nonprofit","lineage":["https://openalex.org/I4405255266"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kiyoshi Yamada","raw_affiliation_strings":["Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, Japan","Pharmaceutical Research Laboratories, Toray Industries, Inc., Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, Japan","institution_ids":["https://openalex.org/I4405255266"]},{"raw_affiliation_string":"Pharmaceutical Research Laboratories, Toray Industries, Inc., Japan","institution_ids":["https://openalex.org/I4210115317"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Atsuhiro Kanda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210120269","display_name":"Taiho Pharmaceutical (Japan)","ror":"https://ror.org/02v50dx14","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210120269"]},{"id":"https://openalex.org/I4405255266","display_name":"Japan Pharmaceutical Manufacturers Association","ror":"https://ror.org/02t1m5632","country_code":"JP","type":"nonprofit","lineage":["https://openalex.org/I4405255266"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Atsuhiro Kanda","raw_affiliation_strings":["Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, Japan","Pharmacobioregulation Research Laboratory, Taiho Pharmaceutical Co., Ltd., Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, Japan","institution_ids":["https://openalex.org/I4405255266"]},{"raw_affiliation_string":"Pharmacobioregulation Research Laboratory, Taiho Pharmaceutical Co., Ltd., Japan","institution_ids":["https://openalex.org/I4210120269"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045753627","display_name":"Toshimasa Ishitsuka","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1306287861","display_name":"Mitsubishi Group (Japan)","ror":"https://ror.org/0234cd281","country_code":"JP","type":"company","lineage":["https://openalex.org/I1306287861"]},{"id":"https://openalex.org/I4405255266","display_name":"Japan Pharmaceutical Manufacturers Association","ror":"https://ror.org/02t1m5632","country_code":"JP","type":"nonprofit","lineage":["https://openalex.org/I4405255266"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Toshimasa Ishitsuka","raw_affiliation_strings":["Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, Japan","Toxicology Laboratory, Mitsubishi Pharma Corporation, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, Japan","institution_ids":["https://openalex.org/I4405255266"]},{"raw_affiliation_string":"Toxicology Laboratory, Mitsubishi Pharma Corporation, Japan","institution_ids":["https://openalex.org/I1306287861"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018379807","display_name":"Takanobu Yamazaki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405255266","display_name":"Japan Pharmaceutical Manufacturers Association","ror":"https://ror.org/02t1m5632","country_code":"JP","type":"nonprofit","lineage":["https://openalex.org/I4405255266"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takanobu Yamazaki","raw_affiliation_strings":["Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, Japan","Research Center, Kyorin Pharmaceutical Co., Ltd., Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, Japan","institution_ids":["https://openalex.org/I4405255266"]},{"raw_affiliation_string":"Research Center, Kyorin Pharmaceutical Co., Ltd., Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110387086","display_name":"Yoichi Kiuchi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144245601","display_name":"Taisho Pharmaceutical (Japan)","ror":"https://ror.org/033nw2736","country_code":"JP","type":"company","lineage":["https://openalex.org/I144245601"]},{"id":"https://openalex.org/I4405255266","display_name":"Japan Pharmaceutical Manufacturers Association","ror":"https://ror.org/02t1m5632","country_code":"JP","type":"nonprofit","lineage":["https://openalex.org/I4405255266"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoichi Kiuchi","raw_affiliation_strings":["Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, Japan","Medicinal Development Research Laboratories, Taisho Pharmaceutical Co., Ltd., Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, Japan","institution_ids":["https://openalex.org/I4405255266"]},{"raw_affiliation_string":"Medicinal Development Research Laboratories, Taisho Pharmaceutical Co., Ltd., Japan","institution_ids":["https://openalex.org/I144245601"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050412338","display_name":"Shinya Taniguchi","orcid":"https://orcid.org/0000-0002-7363-4894","observed_orcids":["https://orcid.org/0000-0002-7363-4894"]},"institutions":[{"id":"https://openalex.org/I4210146667","display_name":"Ajinomoto (Japan)","ror":"https://ror.org/044mkdq33","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210146667"]},{"id":"https://openalex.org/I4405255266","display_name":"Japan Pharmaceutical Manufacturers Association","ror":"https://ror.org/02t1m5632","country_code":"JP","type":"nonprofit","lineage":["https://openalex.org/I4405255266"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shinya Taniguchi","raw_affiliation_strings":["Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, Japan","Pharmaceutical Research Laboratories, Ajinomoto Co., Inc., Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, Japan","institution_ids":["https://openalex.org/I4405255266"]},{"raw_affiliation_string":"Pharmaceutical Research Laboratories, Ajinomoto Co., Inc., Japan","institution_ids":["https://openalex.org/I4210146667"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101624155","display_name":"Tatsuya Mori","orcid":"https://orcid.org/0009-0002-3062-1396","observed_orcids":["https://orcid.org/0009-0002-3062-1396"]},"institutions":[{"id":"https://openalex.org/I4405255266","display_name":"Japan Pharmaceutical Manufacturers Association","ror":"https://ror.org/02t1m5632","country_code":"JP","type":"nonprofit","lineage":["https://openalex.org/I4405255266"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tatsuya Mori","raw_affiliation_strings":["Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, Japan","Toxicological Research Laboratories, Kyowa Hakko Kogyo Co., Ltd., Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, Japan","institution_ids":["https://openalex.org/I4405255266"]},{"raw_affiliation_string":"Toxicological Research Laboratories, Kyowa Hakko Kogyo Co., Ltd., Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076038557","display_name":"Shigekazu Shimizu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405255266","display_name":"Japan Pharmaceutical Manufacturers Association","ror":"https://ror.org/02t1m5632","country_code":"JP","type":"nonprofit","lineage":["https://openalex.org/I4405255266"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shigekazu Shimizu","raw_affiliation_strings":["Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, Japan","Kobuchisawa Laboratories, Fuji Biomedix Co., Ltd., Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, Japan","institution_ids":["https://openalex.org/I4405255266"]},{"raw_affiliation_string":"Kobuchisawa Laboratories, Fuji Biomedix Co., Ltd., Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045998807","display_name":"Yuji Tsurubuchi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405255266","display_name":"Japan Pharmaceutical Manufacturers Association","ror":"https://ror.org/02t1m5632","country_code":"JP","type":"nonprofit","lineage":["https://openalex.org/I4405255266"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yuji Tsurubuchi","raw_affiliation_strings":["Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, Japan","Pharmacological Research Laboratories, Drug Safety Testing Center Co., Ltd., Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, Japan","institution_ids":["https://openalex.org/I4405255266"]},{"raw_affiliation_string":"Pharmacological Research Laboratories, Drug Safety Testing Center Co., Ltd., Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005857385","display_name":"Shun-ichi Yasuda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405255266","display_name":"Japan Pharmaceutical Manufacturers Association","ror":"https://ror.org/02t1m5632","country_code":"JP","type":"nonprofit","lineage":["https://openalex.org/I4405255266"]},{"id":"https://openalex.org/I4405275722","display_name":"Nihon Bioresearch Inc. (Japan)","ror":"https://ror.org/045v61422","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405275722"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shun-ichi Yasuda","raw_affiliation_strings":["Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, Japan","Study Department, Nihon Bioresearch Inc., Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, Japan","institution_ids":["https://openalex.org/I4405255266"]},{"raw_affiliation_string":"Study Department, Nihon Bioresearch Inc., Japan","institution_ids":["https://openalex.org/I4405275722"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043769605","display_name":"Shin-ichi Kitani","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405255266","display_name":"Japan Pharmaceutical Manufacturers Association","ror":"https://ror.org/02t1m5632","country_code":"JP","type":"nonprofit","lineage":["https://openalex.org/I4405255266"]},{"id":"https://openalex.org/I4405274856","display_name":"SNBL INA Ltd. (Japan)","ror":"https://ror.org/02gav4q94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405274856"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shin-ichi Kitani","raw_affiliation_strings":["Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, Japan","Pharmacology & Toxicology Department, Ina Research, Inc., Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, Japan","institution_ids":["https://openalex.org/I4405255266"]},{"raw_affiliation_string":"Pharmacology & Toxicology Department, Ina Research, Inc., Japan","institution_ids":["https://openalex.org/I4405274856"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083282664","display_name":"Chiaki Shimada","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210153309","display_name":"Fuso Pharmaceutical Industries (Japan)","ror":"https://ror.org/041vwff03","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210153309"]},{"id":"https://openalex.org/I4405255266","display_name":"Japan Pharmaceutical Manufacturers Association","ror":"https://ror.org/02t1m5632","country_code":"JP","type":"nonprofit","lineage":["https://openalex.org/I4405255266"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Chiaki Shimada","raw_affiliation_strings":["Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, Japan","Research and Development Center, Fuso Pharmaceutical Industries, Ltd., Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, Japan","institution_ids":["https://openalex.org/I4405255266"]},{"raw_affiliation_string":"Research and Development Center, Fuso Pharmaceutical Industries, Ltd., Japan","institution_ids":["https://openalex.org/I4210153309"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045052116","display_name":"Kazuo Kobayashi","orcid":"https://orcid.org/0000-0002-1284-9728","observed_orcids":["https://orcid.org/0000-0002-1284-9728"]},"institutions":[{"id":"https://openalex.org/I4405255266","display_name":"Japan Pharmaceutical Manufacturers Association","ror":"https://ror.org/02t1m5632","country_code":"JP","type":"nonprofit","lineage":["https://openalex.org/I4405255266"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kazuo Kobayashi","raw_affiliation_strings":["Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, Japan","Pharmacodynamics Research Laboratories, Sankyo Co., Ltd., Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, Japan","institution_ids":["https://openalex.org/I4405255266"]},{"raw_affiliation_string":"Pharmacodynamics Research Laboratories, Sankyo Co., Ltd., Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083517313","display_name":"Masaharu Komeno","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210112155","display_name":"Ono Pharmaceutical (Japan)","ror":"https://ror.org/022jefx64","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210112155"]},{"id":"https://openalex.org/I4405255266","display_name":"Japan Pharmaceutical Manufacturers Association","ror":"https://ror.org/02t1m5632","country_code":"JP","type":"nonprofit","lineage":["https://openalex.org/I4405255266"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masaharu Komeno","raw_affiliation_strings":["Fukui Safety Research Laboratories, Ono Pharmaceutical Co., Ltd., Japan","Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fukui Safety Research Laboratories, Ono Pharmaceutical Co., Ltd., Japan","institution_ids":["https://openalex.org/I4210112155"]},{"raw_affiliation_string":"Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, Japan","institution_ids":["https://openalex.org/I4405255266"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050370819","display_name":"Chieko Kasai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I142395110","display_name":"Astellas Pharma (Japan)","ror":"https://ror.org/01cjash87","country_code":"JP","type":"company","lineage":["https://openalex.org/I142395110"]},{"id":"https://openalex.org/I4405255266","display_name":"Japan Pharmaceutical Manufacturers Association","ror":"https://ror.org/02t1m5632","country_code":"JP","type":"nonprofit","lineage":["https://openalex.org/I4405255266"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Chieko Kasai","raw_affiliation_strings":["Drug Safety Research Laboratories, Astellas Pharma Inc., Japan","Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Safety Research Laboratories, Astellas Pharma Inc., Japan","institution_ids":["https://openalex.org/I142395110"]},{"raw_affiliation_string":"Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, Japan","institution_ids":["https://openalex.org/I4405255266"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043116452","display_name":"Toshiyasu Hombo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I142395110","display_name":"Astellas Pharma (Japan)","ror":"https://ror.org/01cjash87","country_code":"JP","type":"company","lineage":["https://openalex.org/I142395110"]},{"id":"https://openalex.org/I4405255266","display_name":"Japan Pharmaceutical Manufacturers Association","ror":"https://ror.org/02t1m5632","country_code":"JP","type":"nonprofit","lineage":["https://openalex.org/I4405255266"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Toshiyasu Hombo","raw_affiliation_strings":["Drug Safety Research Laboratories, Astellas Pharma Inc., Japan","Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Safety Research Laboratories, Astellas Pharma Inc., Japan","institution_ids":["https://openalex.org/I142395110"]},{"raw_affiliation_string":"Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, Japan","institution_ids":["https://openalex.org/I4405255266"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101289240","display_name":"Keiji Yamamoto","orcid":"https://orcid.org/0000-0002-2800-2329","observed_orcids":["https://orcid.org/0000-0002-2800-2329"]},"institutions":[{"id":"https://openalex.org/I4405255266","display_name":"Japan Pharmaceutical Manufacturers Association","ror":"https://ror.org/02t1m5632","country_code":"JP","type":"nonprofit","lineage":["https://openalex.org/I4405255266"]},{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Keiji Yamamoto","raw_affiliation_strings":["Development Research Center, Takeda Pharmaceutical Co., Ltd., Japan","Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Development Research Center, Takeda Pharmaceutical Co., Ltd., Japan","institution_ids":["https://openalex.org/I44892455"]},{"raw_affiliation_string":"Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, Japan","institution_ids":["https://openalex.org/I4405255266"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":19,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2070,"currency":"USD","value_usd":2070},"apc_paid":null,"fwci":3.4601,"has_fulltext":true,"cited_by_count":46,"citation_normalized_percentile":{"value":0.92965396,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"99","issue":"5","first_page":"423","last_page":"437"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10217","display_name":"Cardiac electrophysiology and arrhythmias","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10217","display_name":"Cardiac electrophysiology and arrhythmias","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10493","display_name":"Ion channel regulation and function","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12281","display_name":"Animal testing and alternatives","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3404","display_name":"Small Animals"},"field":{"id":"https://openalex.org/fields/34","display_name":"Veterinary"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/qt-interval-prolongation","display_name":"QT prolongation","score":0.9259999990463257},{"id":"https://openalex.org/keywords/drug-induced-arrhythmia","display_name":"drug-induced arrhythmia","score":0.7490000128746033},{"id":"https://openalex.org/keywords/action-potential-duration","display_name":"action potential duration","score":0.8560000061988831},{"id":"https://openalex.org/keywords/papillary-muscle","display_name":"papillary muscle","score":0.5849999785423279},{"id":"https://openalex.org/keywords/ikr-blockade","display_name":"IKr blockade","score":0.6949999928474426},{"id":"https://openalex.org/keywords/calcium-current-inhibition","display_name":"calcium current inhibition","score":0.6079999804496765},{"id":"https://openalex.org/keywords/sodium-current-inhibition","display_name":"sodium current inhibition","score":0.9700000286102295},{"id":"https://openalex.org/keywords/cardiac-ion-channels","display_name":"cardiac ion channels","score":0.703000009059906},{"id":"https://openalex.org/keywords/safety-pharmacology","display_name":"safety pharmacology","score":0.8109999895095825},{"id":"https://openalex.org/keywords/terfenadine","display_name":"terfenadine","score":0.718999981880188},{"id":"https://openalex.org/keywords/guinea-pig","display_name":"guinea pig","score":0.7329999804496765}],"concepts":[{"id":"https://openalex.org/C146403970","wikidata":"https://www.wikidata.org/wiki/Q205729","display_name":"Repolarization","level":3,"score":0.7496827244758606},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7124195694923401},{"id":"https://openalex.org/C118441451","wikidata":"https://www.wikidata.org/wiki/Q12074763","display_name":"QT interval","level":2,"score":0.6879245042800903},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6607617735862732},{"id":"https://openalex.org/C2779362680","wikidata":"https://www.wikidata.org/wiki/Q905000","display_name":"hERG","level":3,"score":0.6095813512802124},{"id":"https://openalex.org/C2779303165","wikidata":"https://www.wikidata.org/wiki/Q417909","display_name":"Terfenadine","level":2,"score":0.594581127166748},{"id":"https://openalex.org/C185263204","wikidata":"https://www.wikidata.org/wiki/Q1154774","display_name":"Electrophysiology","level":2,"score":0.5885600447654724},{"id":"https://openalex.org/C79743260","wikidata":"https://www.wikidata.org/wiki/Q2882301","display_name":"Cardiac action potential","level":4,"score":0.5682588219642639},{"id":"https://openalex.org/C83743174","wikidata":"https://www.wikidata.org/wiki/Q423778","display_name":"Potassium channel","level":2,"score":0.5157390236854553},{"id":"https://openalex.org/C2778815084","wikidata":"https://www.wikidata.org/wiki/Q79803","display_name":"Guinea pig","level":2,"score":0.504745364189148},{"id":"https://openalex.org/C17077164","wikidata":"https://www.wikidata.org/wiki/Q1185869","display_name":"Inhibitory postsynaptic potential","level":2,"score":0.4681285619735718},{"id":"https://openalex.org/C50254741","wikidata":"https://www.wikidata.org/wiki/Q62536","display_name":"Ion channel","level":3,"score":0.42048805952072144},{"id":"https://openalex.org/C2910096629","wikidata":"https://www.wikidata.org/wiki/Q241549","display_name":"Anti-Arrhythmia Agents","level":3,"score":0.41344037652015686},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.41085392236709595},{"id":"https://openalex.org/C12554922","wikidata":"https://www.wikidata.org/wiki/Q7100","display_name":"Biophysics","level":1,"score":0.3213125467300415},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2384125292301178},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.19706302881240845},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.19419360160827637},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.16584613919258118},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.136196106672287},{"id":"https://openalex.org/C2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","level":2,"score":0.08748021721839905}],"mesh":[{"descriptor_ui":"D000200","descriptor_name":"Action Potentials","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001681","descriptor_name":"Biological Assay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D004364","descriptor_name":"Pharmaceutical Preparations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006168","descriptor_name":"Guinea Pigs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008133","descriptor_name":"Long QT Syndrome","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010210","descriptor_name":"Papillary Muscles","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D010210","descriptor_name":"Papillary Muscles","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D016208","descriptor_name":"Databases, Factual","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066298","descriptor_name":"In Vitro Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1254/jphs.qt-a1","doi":"https://doi.org/10.1254/jphs.qt-a1","is_oa":true,"landing_page_url":"https://doi.org/10.1254/jphs.qt-a1","pdf_url":"https://www.jstage.jst.go.jp/article/jphs/99/5/99_5_423/_pdf","source":{"id":"https://openalex.org/S163931769","display_name":"Journal of Pharmacological Sciences","issn_l":"1347-8613","issn":["1347-8613","1347-8648"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacological Sciences","raw_type":"journal-article"},{"id":"pmid:16493184","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16493184","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of pharmacological sciences","raw_type":"Comparative Study"},{"id":"pmh:oai:doaj.org/article:a0418258c79346d3ac043532653edbdc","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/a0418258c79346d3ac043532653edbdc","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Pharmacological Sciences, Vol 99, Iss 5, Pp 423-437 (2005)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1254/jphs.qt-a1","doi":"https://doi.org/10.1254/jphs.qt-a1","is_oa":true,"landing_page_url":"https://doi.org/10.1254/jphs.qt-a1","pdf_url":"https://www.jstage.jst.go.jp/article/jphs/99/5/99_5_423/_pdf","source":{"id":"https://openalex.org/S163931769","display_name":"Journal of Pharmacological Sciences","issn_l":"1347-8613","issn":["1347-8613","1347-8648"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacological Sciences","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2074766085.pdf","grobid_xml":"https://content.openalex.org/works/W2074766085.grobid-xml"},"referenced_works_count":49,"referenced_works":["https://openalex.org/W1966363575","https://openalex.org/W1974795857","https://openalex.org/W1975869151","https://openalex.org/W1976589977","https://openalex.org/W1977410911","https://openalex.org/W1988777773","https://openalex.org/W1990637512","https://openalex.org/W1995928952","https://openalex.org/W1998360527","https://openalex.org/W2000262972","https://openalex.org/W2008745305","https://openalex.org/W2013799054","https://openalex.org/W2014659520","https://openalex.org/W2014912931","https://openalex.org/W2016826254","https://openalex.org/W2020928274","https://openalex.org/W2028521745","https://openalex.org/W2029247949","https://openalex.org/W2031082174","https://openalex.org/W2031825791","https://openalex.org/W2049222508","https://openalex.org/W2051669906","https://openalex.org/W2056757939","https://openalex.org/W2063221967","https://openalex.org/W2074724887","https://openalex.org/W2075272123","https://openalex.org/W2078461965","https://openalex.org/W2078999633","https://openalex.org/W2080204738","https://openalex.org/W2083145699","https://openalex.org/W2090153327","https://openalex.org/W2094799470","https://openalex.org/W2113089151","https://openalex.org/W2113927644","https://openalex.org/W2120642757","https://openalex.org/W2131472696","https://openalex.org/W2133290235","https://openalex.org/W2136109751","https://openalex.org/W2150629896","https://openalex.org/W2158798910","https://openalex.org/W2161004893","https://openalex.org/W2168564324","https://openalex.org/W2174038367","https://openalex.org/W2227274237","https://openalex.org/W2321762212","https://openalex.org/W2325885422","https://openalex.org/W2417785422","https://openalex.org/W4235828155","https://openalex.org/W4254462900"],"related_works":["https://openalex.org/W2013799054","https://openalex.org/W2011320128","https://openalex.org/W4412081115","https://openalex.org/W630345756","https://openalex.org/W1508014482","https://openalex.org/W1188856939","https://openalex.org/W1972494248","https://openalex.org/W2014091184","https://openalex.org/W381877730","https://openalex.org/W2106792651"],"abstract_inverted_index":{"To":[0],"construct":[1],"a":[2,31,36,41,63,95,113,147,189],"non-clinical":[3,203],"database":[4],"for":[5,99,125,150,192],"drug-induced":[6],"QT":[7,197],"interval":[8,198],"prolongation,":[9],"the":[10,46,90,117,152,159,165,182,194],"electrophysiological":[11],"effects":[12],"of":[13,89,106,137,155,167,196],"11":[14],"positive":[15,122],"and":[16,74,86,127,177],"10":[17],"negative":[18,129],"compounds":[19,123,130],"on":[20,45],"action":[21,55,82,183],"potentials":[22],"(AP)":[23],"in":[24,30,62,116,200,202],"guinea-pig":[25],"papillary":[26],"muscles":[27],"were":[28],"investigated":[29],"multi-site":[32],"study":[33],"according":[34],"to":[35,103,112],"standard":[37],"protocol.":[38],"Compounds":[39],"with":[40,131],"selective":[42],"inhibitory":[43],"effect":[44],"rapidly":[47],"activated":[48],"delayed":[49],"rectifier":[50],"potassium":[51],"current":[52,69,78],"(IKr)":[53],"prolonged":[54,134],"potential":[56,83,184],"duration":[57],"at":[58],"90%":[59],"repolarization":[60],"(APD90)":[61],"concentration-dependent":[64],"manner,":[65],"those":[66,75],"showing":[67,76],"Ca2+":[68],"(ICa)":[70],"inhibition":[71,80],"shortened":[72],"APD30,":[73],"Na+":[77],"(INa)":[79],"decreased":[81],"amplitude":[84],"(APA)":[85],"Vmax.":[87],"Some":[88],"mixed":[91],"ion-channel":[92],"blockers":[93],"showed":[94],"bell-shaped":[96],"concentration-response":[97],"curve":[98],"APD90,":[100],"probably":[101],"due":[102],"their":[104,138],"blockade":[105],"INa":[107],"and/or":[108,140],"ICa,":[109],"sometimes":[110],"leading":[111],"false-negative":[114],"result":[115],"assay.":[118],"In":[119],"contrast,":[120],"all":[121,128],"except":[124],"terfenadine":[126],"IKr-blocking":[132,153],"activity":[133,154],"APD30-90":[135,145,178],"regardless":[136],"INa-":[139],"ICa-blocking":[141],"activities,":[142],"suggesting":[143],"that":[144],"is":[146,161],"useful":[148,190],"parameter":[149],"evaluating":[151],"test":[156,172],"compounds.":[157,173],"Furthermore,":[158],"assay":[160,185],"highly":[162],"informative":[163],"regarding":[164],"modulation":[166],"cardiac":[168],"ion":[169],"channels":[170],"by":[171],"Therefore,":[174],"when":[175],"APD90":[176],"are":[179],"both":[180],"measured,":[181],"can":[186],"be":[187],"considered":[188],"method":[191],"assessing":[193],"risk":[195],"prolongation":[199],"humans":[201],"safety":[204],"pharmacology":[205],"studies.":[206]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}